|Bid||14.05 x 800|
|Ask||23.51 x 900|
|Day's range||17.31 - 18.16|
|52-week range||15.88 - 26.84|
|Beta (5Y monthly)||1.29|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
NEW BRIGHTON, Minn., May 04, 2022--APi Group Corporation (NYSE: APG) ("APG", "APi" or the "Company") today reported its financial results for the three months ended March 31, 2022.
NEW BRIGHTON, Minn., April 21, 2022--APi Group Corporation (NYSE: APG) ("APG", "APi" or the "Company"), announced today that it intends to release its first quarter financial results for the three months ended March 31, 2022 before the market opens on Wednesday, May 4, 2022.
Global Pharmaceutical API Manufacturing Market Global Pharmaceutical API Manufacturing Market Dublin, April 13, 2022 (GLOBE NEWSWIRE) -- The "Pharmaceutical API Manufacturing Global Market Report 2022: By Therapy, By API, By Drug" report has been added to ResearchAndMarkets.com's offering. The global pharmaceutical API manufacturing market is expected to grow from $179.05 billion in 2021 to $195.29 billion in 2022 at a compound annual growth rate (CAGR) of 9.1%. The growth is mainly due to the c